DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)

South Korea · Delayed Price · Currency is KRW

5,250.00

-120.00 (-2.23%)

At close: Apr 21, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017	FY 2016	FY 2015
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Marketing Agency			2.36B	1.12B	-	-	-
Marketing Agency Growth			110.99%	-	-	-	-
Financial Industry			966.08M	709.83M	-	-	-
Financial Industry Growth			36.10%	-	-	-	-
Connection Adjustment			-2.52B	-1.27B	-	-	-
Medicine			214.88B	194.43B	-	-	-
Medicine Growth			10.51%	-	-	-	-
Pharmaceuticals			-	-	155.15B	139.22B	101.12B
Pharmaceuticals Growth			-	-	11.45%	37.67%	15.75%
Total			215.69B	194.99B	155.15B	139.22B	101.12B
Total Growth			10.62%	25.68%	11.45%	37.67%	15.75%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017	FY 2016	FY 2015
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea			212.14B	194.99B	155.15B	139.22B	101.12B
South Korea Growth			8.80%	25.68%	11.45%	37.67%	15.75%
Overseas			2.92B	-	-	-	-
Total			215.06B	194.99B	155.15B	139.22B	101.12B
Total Growth			10.30%	25.68%	11.45%	37.67%	15.75%

Source: S&P Global Market Intelligence.